Microalgae are gaining recognition as sustainable, nutrient-rich sources of bioactive compounds, including proteins, lipids, ...
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities. Andrew Ward ...
The company will invest part of the divestment proceeds in its growing pipeline of value adding and specialty pharmaceutical products. In addition, the company is exploring different strategic options ...
The data surveyed by Reuters came from pharmaceutical regulators in Australia ... manufacture semaglutide-based medicines and that their products are shipped overseas. At least three of these ...
Now, some of them are looking for alternatives as geopolitical tensions rise. From big pharmaceutical companies such as AstraZeneca to small biotechnology firms like Amicus Therapeutics of New ...
The Federal Ministry of Health and Social Welfare is set to implement zero Value Added Tax and excise duties on pharmaceutical products and medical devices. A statement signed on Thursday by the ...
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities. Recruiting ...
that enable the manufacturing of pharmaceutical products with minimal human intervention. 3 Pharma 4.0 has enabled a significant reduction in resource utilization. A higher data density inspired ...
Telix Pharmaceuticals won’t raise capital as it looks to capture the attention of more global investors under fresh plans to list on the Nasdaq ... cancer imaging product Illuccix in the ...
The management of the Afe Babalola University, Ado-Ekiti (ABUAD) on Monday said the institution has commenced production of plant-based pharmaceutical products. ABUAD Vice Chancellor, Smaranda ...
The proposed acquisition represents a significant step forward in Lundbeck’s Focused Innovator strategy, adding a highly innovative and complementary product in late-stage development for ...